Company Monitoring Page for Eisai

latest headlines for company on cafepharma

6 Drugs Approved Despite Failed Trials or Minimal Data
BioSpace
Mon, 10/9/23 - 11:10 am
Tags:
Ipsen, Sohonos, Sarepta Therapeutics, Elevidys, Biogen, Qalsody, Eisai, Aduhelm, Jazz Pharma, PharmaMar, Zepzelca, Acadia Pharma, Nuplazid
Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen
Reuters
Tue, 09/26/23 - 10:23 am
Tags:
Biogen, Eisai, Japan, Leqembi, Alzheimer's disease
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Tags:
Merck, Eisai, Keytruda, Lenvima, melanoma, colorectal cancer, non-small cell lung cancer
Eisai launches digital dementia specialist company
Pharmaphorum
Tue, 09/12/23 - 12:06 pm
Tags:
Eisai, digital health, dementia, Theoria Technologies
The Alzheimer’s Treatment Landscape: Leqembi vs. Donanemab
BioSpace
Mon, 09/11/23 - 11:56 am
Tags:
Alzheimer's disease, Eli Lilly, Biogen, Eisai, Leqembi, donanemab
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Tags:
Merck, Eisai, Keytruda, Lenvima, clinical trials, head and neck cancer
New Alzheimer’s drug raises hopes — along with questions
Medical Marketing and Media
Mon, 08/14/23 - 06:54 pm
Tags:
FDA, Alzheimer's disease, Eisai, Biogen, Leqembi
The real costs of the new Alzheimer’s drug, most of which will fall to taxpayers
Medical Marketing and Media
Wed, 08/2/23 - 10:43 pm
Tags:
Eisai, Biogen, Leqembi, Alzheimer's disease
After winning full FDA nod for Leqembi, Eisai touts 'promising' study on subcutaneous version
Fierce Pharma
Thu, 07/20/23 - 10:09 am
Tags:
Eisai, Biogen, Leqembi, FDA, Alzheimer's disease, subcutaneous drug delivery
Lilly’s donanemab flaunts strong clinical profile, ready to compete with Leqembi
Clinical Trials Arena
Wed, 07/19/23 - 10:27 am
Tags:
Eli Lilly, donanemab, Eisai, Biogen, Leqembi, Alzheimer's disease
Medicare’s Proposed Coverage for Alzheimer’s Scan Could Be Boon for Eisai/Biogen
BioSpace
Tue, 07/18/23 - 11:36 am
Tags:
CMS, Alzheimer's disease, Eisai, Biogen, PET scans
Why new Alzheimer’s drugs are in for a tepid launch
Medical Marketing and Media
Sun, 07/16/23 - 03:11 pm
Tags:
Alzheimer's disease, drug launches, Biogen, Eisai, Leqembi
Why Isn't Biogen Stock Soaring After This Major FDA Approval?
Motley Fool
Thu, 07/13/23 - 10:16 am
Tags:
Biogen, Eisai, Leqembi, Alzheimer's disease
How will the price of Eisai and Biogen's Leqembi impact Medicare? Sen. Sanders wants to know
Fierce Pharma
Wed, 07/12/23 - 11:03 pm
Tags:
Eisai, Biogen, Leqembi, drug pricing, Medicare, Alzheimer's disease
Eisai's US CEO and Alzheimer's lead Ivan Cheung telegraphs retirement days after Leqembi's full FDA nod
Fierce Pharma
Tue, 07/11/23 - 11:20 pm
Tags:
Eisai, Alzheimer's disease, Leqembi, Ivan Cheung
Leqembi Wins Full FDA Approval as First Anti-Amyloid Antibody for Alzheimer’s
BioSpace
Thu, 07/6/23 - 10:08 pm
Tags:
Biogen, Eisai, Leqembi, FDA, Alzheimer's disease
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
Tags:
FDA, Eisai, Biogen, Leqembi, Alzheimer's disease, SAGE Therapeutics, zuranolone, postpartum depression, major depressive disorder, Roche, Tecentriq, non-small cell lung cancer, CRISPR Therapeutics, Bluebird Bio, lovo-cel, exa-cel, BrainStorm Cell Therapeutics, NurOwn
5 FDA decisions to watch in the third quarter
BioPharma Dive
Mon, 06/26/23 - 10:04 am
Tags:
FDA, SAGE Therapeutics, Biogen, zuranolone, Eisai, Leqembi, Sanofi, AstraZeneca, nirsevimab, Iveric Bio, Zimura, Alnylam, Onpattro
Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?
Motley Fool
Fri, 06/23/23 - 10:03 am
Tags:
Biogen, Eisai, Alzheimer's disease, FDA, Leqembi
Does This Signal Trouble for Biogen's New Alzheimer's Drug?
Motley Fool
Mon, 06/19/23 - 10:21 am
Tags:
Eisai, Biogen, Leqembi, Alzheimer's disease, Europe

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.